ClinicalTrials.Veeva

Menu

Ketamine Treatment Plans for Chronic Conditions

R

RIVER Foundation

Status

Enrolling

Conditions

Chronic Disease
Chronic Pain
Anxiety Disorders
Depressive Disorder

Treatments

Drug: Ketamine

Study type

Observational

Funder types

Other

Identifiers

NCT06038409
RIVERFoundation 001

Details and patient eligibility

About

A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.

Full description

Ketamine can be administered in multiple ways (IV, IM, SubQ, and Sublingual, among others), and there have been few if any, studies that have compared the impact of Ketamine at home without any thearpy.

The study will identify other treatment modalities used in concurrence with Ketamine. Psychotherapy, music therapy, and acutherapy are some of the most popular. How do these adjunct therapies affect the outcomes of Ketamine treatments?

Secondarily, the study will focus on these significant issues to observe the impact of Ketamine treatments and suicidal ideation. Suicidal ideation is multifaceted and is one reason for prescribing off-label Ketamine. Chronic issues such as depression, pain, and anxiety have been identified as underlying causes and may be improvable with Ketamine.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Must have an identifiable chronic condition.

Exclusion criteria

Healthy population

Trial design

500 participants in 4 patient groups

Chronic Pain
Description:
The use of ketamine in chronic pain
Treatment:
Drug: Ketamine
Depressive Disorders
Description:
The use of ketamine in depressive disorders
Treatment:
Drug: Ketamine
Anxiety Disorders
Description:
The use of ketamine in anxiety disorders
Treatment:
Drug: Ketamine
Chronic Condtions
Description:
The use of ketamine in chronic conditions
Treatment:
Drug: Ketamine

Trial contacts and locations

1

Loading...

Central trial contact

James Taggart, MD; Ed Lesofski

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems